Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 9:5:473-81.
doi: 10.2147/ijn.s10879.

Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing

Affiliations

Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing

Mohamad Alameh et al. Int J Nanomedicine. .

Abstract

Chitosan, a well known natural cationic polysaccharide, has been successfully implemented in vitro and in vivo as a nonviral delivery system for both plasmid DNA and siRNA. While using chitosan/siRNA polyplexes to knock down specific targets, we have underestimated the effect of nucleic acids binding to chitosan when extracting RNA for subsequent quantitative PCR evaluation of silencing. In vitro transfection using chitosan/siRNA-based polyplexes reveals a very poor recovery of total RNA especially when using low cell numbers in 96 well plates. Here, we describe a method that dramatically enhances RNA extraction from chitosan/siRNA-treated cells by using an enzymatic treatment with a type III chitosanase. We show that chitosanase treatment prior to RNA extraction greatly enhances the yield and the integrity of extracted RNA. This method will therefore eliminate the bias associated with lower RNA yield and integrity when quantifying gene silencing of chitosan-based systems using quantitative real time PCR.

Keywords: DPP-IV gene silencing; RIN; chitosan; chitosanase; qPCR; siRNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
FACS analysis of chitosan/DPP-IVODN polyplexes uptake in HepG2 cell line. Uptake of 5′-6FAM labeled DPP-IVODN in chitosanase treated and untreated cells 24 hours post transfection. (A) Transfection efficiency was calculated as the percentage of 5′FAM-DPP-IVODN labelled cells. (B) The relative amount of internalized DPP-IVODN was determined using flow cytometry and is expressed as the median of fluorescence intensity (FI) of the 6FAM-DPP-IVODN positive cells. Data points represent the mean values ± SD, n = 3.*P < 0.05; **P < 0.01.
Figure 2
Figure 2
Confocal imaging of polyplexes uptake. Confocal microscopy images of HepG2 live cells 24 hours post transfection with chitosan/DPP-IVODN polyplexes (N/P = 5). Chitosan 92–10 (DDA, MW) was labeled with Rhodamine (red), the DPP-IVODN with 6FAM at the 5′extremity (green), and the cell membranes were stained prior to imaging with cell mask (blue). Membrane staining was performed to differentiate between internalized and membrane bound polyplexes.
Figure 3
Figure 3
Effect of Streptomyces griseus chitosanase on yield and integrity of total RNA extraction. Total RNA extraction was performed on HepG2 cells transfected with 10 pmol and 50 pmol of nanoparticles siRNA/chitosan at three different N/P ratios indicated by the formulation code 92-10-5, 92-10-10, or 92-10-20 (DDA, MW, N/P). Chitosanase was resuspended in DMEM pH 6.5 and directly applied to cells at a final concentration of 6.12 mU/μg of chitosan. Total RNA was extracted from chitosan transfected cell treated with or without chitosanase. The different extractions were compared to control Dharmafect™ 1 transfected cells and nontransfected (NT) cells. (nt) = nucleotide, L = standard ladder, the green band is a lower marker, which allows sample alignment and permits comparison for RIN calculation. RIN = RNA integrity number, is an algorithm-based numbering system that calculates-RNA integrity with 10 being the most intact and 1 being fully degraded.
Figure 4
Figure 4
Polyacrylamide gel electrophoresis of chitosan/DPP-IVODN polyplexes bearing different DDAs and N/P ratios, treated with or without Streptomyces griseus chitosanase. a) chitosan migration. b) ODN migration. Lanes 1 to 4 correspond to chitosan/DPP-IVODN directly incubated with chitosanase for 60 minutes at 37°C. Chitosan digestion allows the ODN release. Lanes 5 to 8 correspond to chitosan/DPP-IVODN incubated at the similar conditions without chitosanase. Faster chitosan migration was observed when comparing lanes 5 and 6 due to different MW of theses formulations. Increased band intensity (lanes 6–8) results from greater amounts of chitosan at higher N/P ratios.
Figure 5
Figure 5
Total RNA extraction from HepG2 transfected cells with 10 pmol siRNA. Following transfection, cells were treated with chitosanase for: 30 min and 60 min in cell medium and for 60 min in lysis buffer.

References

    1. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15:1326–1331. - PubMed
    1. Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res. 2004;21:344–353. - PubMed
    1. Zhang H, Neau SH. In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation. Biomaterials. 2001;22:1653–1658. - PubMed
    1. Prego C, Torres D, Alonso MJ. Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness. J Nanosci Nanotechnol. 2006;6:2921–2928. - PubMed
    1. Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res. 2006;23:549–556. - PubMed

Publication types